已发表论文

中国海口地区肿瘤医疗保健提供者对卵巢癌化疗所致骨髓抑制的认知、态度和实践

 

Authors Liu X, Tao J

Received 9 April 2025

Accepted for publication 13 September 2025

Published 15 October 2025 Volume 2025:18 Pages 6733—6744

DOI https://doi.org/10.2147/JMDH.S533373

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr David C. Mohr

Xiaohang Liu,1 Jiashou Tao2 

1Department of Gynecology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, People’s Republic of China; 2Department of Hepatobiliary Surgery, Hainan Cancer Hospital, Haikou, Hainan, 570000, People’s Republic of China

Correspondence: Jiashou Tao, Email 27966662@qq.com

Purpose: Chemotherapy-induced myelosuppression can profoundly affect patient prognosis. This study assessed the knowledge, attitude, and practice (KAP) of oncology healthcare providers regarding chemotherapy-induced myelosuppression in patients with ovarian cancer.
Patients and Methods: This cross-sectional study was conducted at Hainan General Hospital from September 14 to December 12, 2023, and enrolled oncology healthcare providers. A self-designed questionnaire (Cronbach’s α=0.826) was used to collect participant characteristics and KAP scores. Multivariable logistic regression and structural equation modeling (SEM) analyses were performed to determine the factors influencing KAP and the relationships among KAP dimensions.
Results: The analysis included 516 participants. The median knowledge, attitude, and practice scores were 31 (19, 35) (/36, 86.11%), 23 (18, 27) (/35, 65.71%), and 39 (29, 45.5) (/50, 78.00%), respectively. The multivariable analysis showed that the female gender (OR=0.481, 95% CI: 0.259– 0.893, P=0.020), oncologist (OR=0.451, 95% CI: 0.220– 0.923, P=0.029), gynecology nurse (OR=2.530, 95% CI: 1.121– 5.709, P=0.025), oncology nurse (OR=2.225, 95% CI: 1.061– 4.664, P=0.034), knowledge score > 31 (OR=13.969, 95% CI: 7.615– 25.625, P< 0.001), and attitude score > 23 (OR=9.127, 95% CI: 5.111– 16.300, P< 0.001) were independently associated with a practice score > 39. In the adjusted SEM, knowledge directly influenced attitude (β=0.817, P=0.010) and practice (β=0.349, P=0.010), attitude directly influenced practice (β=0.566, P=0.010), and knowledge indirectly influenced practice (β=0.462, P=0.010).
Conclusion: This study revealed that oncology healthcare providers in oncology and obstetrics/gynecology in Haikou, China, had good knowledge and practice but moderate attitudes regarding chemotherapy-induced myelosuppression in patients with ovarian cancer. This study identified categories of healthcare providers who would benefit from educational activities and training. Improving the KAP toward chemotherapy-induced myelosuppression in cancer patients could help improve patient outcomes. Policymakers should also facilitate the KAP improvements in healthcare professionals.

Keywords: ovarian cancer, chemotherapy, myelosuppression, healthcare providers, KAP, cross-sectional study